Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 32,506

Document Document Title
WO/2019/040389A1
The present invention relates novel furan based amine cross-linkers with improved thermomechanical and water barrier properties. The novelty of this invention is the use of aromatic, and hydrophobic aliphatic aldehydes to bridge two furf...  
WO/2019/040418A1
Compounds and methods for treating viral infections and reducing viral multiplication, including flaviviruses. Provided is a derivative of a compound or a pharmaceutical salt thereof, wherein the compound comprises a 3',4-didehydroribose.  
WO/2019/040467A1
α-Cyanoacrylamide and α-cyanoacrylate compounds that allosterically inhibit Myeloid Cell Leukemia-1 (Mcl-1) oncoprotein, and methods of using the same, are provided for treating disease.  
WO/2019/040335A1
The present invention relates to derivatives of the sesquiterpene lactone micheliolide, methods and compositions for their preparation, and methods for using the micheliolide derivatives in pharmaceutical compositions as anticancer and a...  
WO/2019/039705A1
The present invention relates to a method for separating 5-hydroxymethyl-2-furfural (HMF) and dimethyl sulfoxide (DMSO), the method comprising the steps of: (a) preparing a mixture solution comprising HMF and DMSO; and (b) mixing an orga...  
WO/2019/040005A1
Disclosed herein is a nanoparticulate material comprising graphene quantum dots (GQDs) having a first and second surface, each surface comprising one or more functional groups; and may additionally comprises of metal-containing nanoparti...  
WO/2019/034461A1
Described is a process of separating 2,5-diformylfuran from an aqueous mixture comprising dissolved 5-(hydroxymethyl)furfural, dissolved 2,5-diformylfuran and a buffer substance, comprising the step of (a) cooling down the mixture so tha...  
WO/2019/033219A1
A class of compounds useful in pharmaceutical compositions and methods for treating or preventing cancer is described. Analogs of Mycalolide B have been prepared and tested in breast and ovarian cancer cell lines. The compounds show util...  
WO/2019/035412A1
This organic electroluminescence element includes an anode, a cathode, and an organic layer disposed between the anode and the cathode. The organic layer includes a light-emitting layer and at least one layer disposed between the light-e...  
WO/2019/036374A1
Described herein are compounds, or pharmaceutically acceptable salts thereof, of the following formula (I). The compounds are useful for treating inflammatory and autoimmune diseases.  
WO/2019/031833A1
Disclosed are a compound represented by chemical formula 1, an organic electronic element comprising a first electrode, a second electrode, and an organic layer between the first electrode and the second electrode, and an electronic devi...  
WO/2019/031605A1
Provided is a fused ring compound which exhibits excellent charge transport ability. A fused ring compound which is represented by formula (1) and has a specific structure.  
WO/2019/025540A1
The invention relates to 3-acyl-benzamides of formula (I) as herbicides. In formula (I) X, Y, Z and Rx represent radicals such as alkyl, cycloalkyl and halogen.  
WO/2019/025467A1
The present disclosure relates to compounds of Formula (I): (I); and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful fo...  
WO/2019/024635A1
Provided are a 1,3-di-substituted ketene compound having a structure as represented by formula (I) and an application thereof. Such a type of compound primarily activates peroxisome proliferator-activated receptor (PPAR) α, and also act...  
WO/2019/021146A1
Provided is a novel organic compound. Also provided is a novel organic compound having hole transport properties. Further provided is a novel hole transport material. A novel light-emitting element is also provided. A light-emitting elem...  
WO/2019/020654A1
The present application relates to a spirobifluorene derivative of a specific formula (I) which is suitable for use in electronic devices.  
WO/2019/023147A1
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured.The variables shown in Formula AA are as defined in the claims. The compounds of formula AA are NLRP3 activity modulators and, as such, c...  
WO/2019/020773A1
The present invention relates to a new bio-sourced vanillin and/or ethylvanillin, containing specific impurities. The invention further relates to a process for their preparations and the use of such compounds.  
WO/2019/023145A1
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured. The variables shown in Formula AA are as defined in the claims. The compounds of formula AA are NLRP3 activity modulators and, as such, ...  
WO/2019/022562A1
The present specification provides a compound of chemical formula 1 and an organic light emitting element comprising the same.  
WO/2019/018588A1
Zinc:usnic acid complexes having a 1:2 zinc to usnate molar ratio and methods of preparing them. Oral care compositions comprising the Zn:usnate complexes may be useful to improve oral health.  
WO/2019/017730A1
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.  
WO/2019/017468A1
Provided is a production method by which 2,5-bis(aminomethyl)furan can be efficiently produced. This 2,5-bis(aminomethyl)furan production method comprises a step for producing 2,5-bis(aminomethyl)furan by reacting hydrogen and an amine c...  
WO/2019/018287A1
Disclosed herein are personal care compositions comprising Zn:usnate complexes having a 1:2 zinc to usnate molar ratio. Methods of making and using the compositions are also provided. The personal care compositions may include a cleansin...  
WO/2019/017734A1
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.  
WO/2019/017731A1
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.  
WO/2019/016269A1
The present invention relates to derivatives of formula (I) which bind to the liver X receptor (LXRα and/or LXRβ) and act preferably as inverse agonists of LXR.  
WO/2019/013299A1
The present invention provides a thermally conductive material that has excellent thermal conductivity. The present invention also provides: a device that is provided with a thermally conductive layer that includes the thermally conducti...  
WO/2019/011285A1
Disclosed are a tetrahydronaphtho[1,2-b]furan-2(3H)-one derivative having a chemical structure as shown in formula I, and a preparation method therefor. The tetrahydronaphtho[1,2-b]furan-2(3H)-one derivative can be used in the preparatio...  
WO/2019/011200A1
The invention relates to a preparation method of a pyridinecarboxamide derivative and an intermediate thereof wherein the reaction step is shortened, the reaction yield is improved, the method is simple and easy to control, and is advant...  
WO/2019/013509A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2019/014382A1
The present disclosure provides processes for the purification of 2,5-furandicarboxylic acid (FDCA). The present disclosure further provides crystalline preparations of purified FDCA, as well as processes for making the same. In addition...  
WO/2019/013487A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2019/013503A1
The present invention relates to a novel organic compound and an organic electroluminescent element including the same and, more specifically, to: a novel dibenzofuran-based compound having excellent thermal stability, carrier transport ...  
WO/2019/014393A1
The present disclosure provides processes for the production of 2,5-furandicarboxylic acid (FDCA) from various substrates, including C6-aldaric acids and lactones of C6-aldaric acids.  
WO/2019/007415A1
Disclosed are a furan-naphthoquinone-based sulfoximine derivative as shown in formula (I), a pharmaceutical composition containing the derivative and the use of the derivative as an STAT3 inhibitor.  
WO/2019/007821A1
The invention relates to 4,6-dihalogen-dibenzothiophene and 4,6-dihalogen-dibenzofuran-3-thioether derivatives of formula (I), in which W, X, R1, R2, A1, Z1 and n are defined as cited in claim 1, to their production, their use as compone...  
WO/2019/004777A1
An embodiment of the present invention provides a method for preparing 2,5-furandimethylcarboxylate (FDMC), the method comprising a step for preparing 2,5-furandimethylcarboxylate (FDMC) by an acidic esterification reaction of a reactant...  
WO/2019/002190A1
The present application relates to a spirobifluorene derivative of a specific formula (I) which is suitable for use in electronic devices.  
WO/2019/000069A1
Disclosed is a cost-effective process for catalytic conversion of simple C6-based sugars (such as glucose and fructose) and industrial-grade sugar syrups derived from starch (such as different grades of High Fructose Corn Syrup) and cell...  
WO/2019/004614A1
The present invention provides a novel heterocyclic compound and an organic light emitting element using same.  
WO/2018/236928A1
The invention provides novel classes of HCV therapeutics that are orally available, safe and effective HCV NS3/4A protease inhibitors and are less susceptible to drug resistance than existing therapeutics. The invention also relates to p...  
WO/2018/236913A1
Small molecule calpain modulator compositions and pharmaceutical compositions can be prepared and used as therapeutic agents. Exemplary compositions include non-macrocyclic a-keto amide derivatives. The therarapeutic agents can be used f...  
WO/2018/236146A1
The present invention relates to a compound of chemical formula 1, a coating composition comprising the same, and an organic light emitting element comprising the same.  
WO/2018/235012A1
Process for producing levulinic acid, wherein a carbohydrate-based substrate is subjected to a treatment step in aqueous environment at acid pH at a temperature from 120°C to 200°C, so as to obtain a reaction mixture comprising levulin...  
WO/2018/232527A1
The present invention describes complex topical aqueous compositions for the effective delivery of active ingredients such as putrescine and Vitamin C into the skin. These compositions may be used in a variety of cosmetic and therapeutic...  
WO/2018/236182A1
The present specification provides a compound of chemical formula 1 and an organic electroluminescent device comprising same.  
WO/2018/236218A1
The present invention, relates to processes for the production and conversion of furan compounds. In certain embodiments the invention concerns the conversion of furfural compounds into a so-called Knoevenagel products and for the furthe...  
WO/2018/236948A1
The present invention relates to a process for making the esters of 2,5-furandicarboxylic acid, and particularly the dimethyl, diethyl or dipropyl esters of FDCA for use as monomers in the production of polyesters and other types of poly...  

Matches 51 - 100 out of 32,506